Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Research
Biotech
ARPA-H goes all in on in vivo cell therapy
One of the grant winners is a newly emerged biotech called ImmunoVec, which debuted with up to $40.7 million in funding from ARPA-H.
Darren Incorvaia
Oct 8, 2025 4:04pm
Sanofi inks pact with Canadian tech company to bring AI to R&D
Oct 8, 2025 12:13pm
Sponsored
Peptide Synthesis and the Hidden Complexities of Scaling Peptide Therapeutics
Oct 6, 2025 8:00am
GLD flexes muscle-wasting ambitions, launching Altagenics
Oct 7, 2025 10:01am
AstraZeneca, Algen Biotechnologies pen $555M AI pact
Oct 6, 2025 8:00am
3 scientists win Nobel Prize for discovery of regulatory T cells
Oct 6, 2025 7:03am